newsfilter
← Latest News
GlobeNewswire·

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress Scripts national formulary coverage secured as company makes progress